APA (7th ed.) Citation

Verbsky, J. W., Hintermeyer, M. K., Simpson, P. M., Feng, M., Barbeau, J., Rao, N., . . . Routes, J. M. (2021). Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency. Journal of allergy and clinical immunology, 147(2), 704-712.e17. https://doi.org/10.1016/j.jaci.2020.07.021

Chicago Style (17th ed.) Citation

Verbsky, James W., et al. "Rituximab and Antimetabolite Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency." Journal of Allergy and Clinical Immunology 147, no. 2 (2021): 704-712.e17. https://doi.org/10.1016/j.jaci.2020.07.021.

MLA (9th ed.) Citation

Verbsky, James W., et al. "Rituximab and Antimetabolite Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency." Journal of Allergy and Clinical Immunology, vol. 147, no. 2, 2021, pp. 704-712.e17, https://doi.org/10.1016/j.jaci.2020.07.021.